Rapid quantitative determination of doxorubicin and its metabolites in biological samples
- PMID: 2735565
Rapid quantitative determination of doxorubicin and its metabolites in biological samples
Abstract
A rapid sensitive and selective method is developed for the plasma analysis of doxorubicin and its metabolites, doxorubicinol and doxorubicinone with daunorubicin as the internal standard, by using high performance liquid chromatography (HPLC) with fluorescence detection and a "zorbax ODS" column. An eluent containing tetrahydrofuran and trietylamine afforded improved efficiency and resolution and was used to resolve the four anthracycline derivatives in a sole isocratic run. An example of the plasma levels obtained in a cancerous patient after two different administrations is shown.
Similar articles
-
Determination of doxorubicin and doxorubicinol in plasma of cancer patients by high-performance liquid chromatography.Anal Biochem. 1999 Jan 15;266(2):216-21. doi: 10.1006/abio.1998.2943. Anal Biochem. 1999. PMID: 9888978
-
Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.Drug Metab Dispos. 1980 May-Jun;8(3):152-6. Drug Metab Dispos. 1980. PMID: 6104578
-
Rapid quantitative determination of epirubicin and its metabolites in plasma using high performance liquid chromatography and fluorescence detection.Biomed Chromatogr. 1990 Jan;4(1):20-3. doi: 10.1002/bmc.1130040103. Biomed Chromatogr. 1990. PMID: 2310837
-
Anthracycline assay by high-pressure liquid chromatography.J Pharm Sci. 1981 Mar;70(3):265-9. doi: 10.1002/jps.2600700309. J Pharm Sci. 1981. PMID: 6943332
-
Improved HPLC method for doxorubicin quantification in rat plasma to study the pharmacokinetics of micelle-encapsulated and liposome-encapsulated doxorubicin formulations.Biomed Chromatogr. 2008 Nov;22(11):1252-8. doi: 10.1002/bmc.1054. Biomed Chromatogr. 2008. PMID: 18651589
Cited by
-
Chronopharmacokinetics of doxorubicin in patients with breast cancer.Eur J Clin Pharmacol. 1991;40(3):287-91. doi: 10.1007/BF00315211. Eur J Clin Pharmacol. 1991. PMID: 2060566 Clinical Trial.